Item 2.02 Results of Operations and Financial Condition
As discussed below, in connection with participation in the 40th Annual
Because the Company's consolidated financial statements for the year ended
Item 7.01 Regulation FD Disclosure
Beginning on
A copy of the Company's corporate presentation is attached hereto as Exhibit 99.1 and is hereby incorporated by reference herein.
The information contained in Item 2.02 and Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is furnished pursuant to Item 2.02 and Item 7.01 of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except as expressly stated by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits. Exhibit Number Description 99.1Aprea Therapeutics, Inc. Presentation 104 The cover page from this Current Report on Form 8-K, formatted as Inline XBRL
© Edgar Online, source